JBPT is an international, double-blind peer-reviewed, fully open-access journal dedicated to publishing high-quality researches at the interface of molecular biology, pathology, pathogenesis, and therapeutic advancements.
JBPT is a fully open-access journal, meaning all content is made immediately and permanently available online to users and institutions without subscription barriers or financial hurdles. Users are permitted to read, download, copy, distribute, print, search, or link to the full texts of all articles, or utilize them for any other lawful purpose under creative commons protocols, without requesting prior permission from the publisher or the authors, provided appropriate academic credit is given to the original creators and any modifications are clearly indicated.
JBPT serves as a high-quality peer-reviewed platform for the dissemination of original and innovative research in the biomedical, clinical, and translational sciences. The journal is dedicated to advancing scientific understanding of interdisciplinary research that integrates molecular biology, pathophysiology, clinical pathogenesis, diagnostic methodologies, and therapeutic interventions.
Authors are highly encouraged to prepare manuscripts in strict compliance with the target Manuscript Preparation Guidelines to avoid immediate technical rejections or delays. Core authorship definitions and contribution allocations strictly mirror the global standards set by the ICMJE Authorship Framework.
Publisher Corporate Identity: The Journal of Biomolecules, Pathogenesis and Therapeutics (JBPT) is published by the Multidisciplinary Scholarly Advancement and Research MSAR Institute, based in Lahore, Punjab, Pakistan.
